Company Solutions

X100 With Full Field Peripheral Blood Smear Application (FFM-PBS)

The FDA-cleared and CE certified, Full Field Peripheral Blood Smear (PBS) Application gives hematology laboratories of all sizes reliable, consistent and accelerated diagnostic capabilities.

Scopio’s breakthrough FFM technology provides a full field scan of the monolayer and the feathered edge with cell images at 100X oil immersion resolution.

While other digital microscopy solutions offer single-cell snapshots, with Scopio you get the full context of the slide, in high resolution, without sacrificing the size of the field of view and without the need to default to the manual microscope.

Digital Microscopy: no more trade-off between resolution and field-of-view

Scopio Labs has created the highest resolution, highest quality digital microscopy platform using computational photography. Scopio’s unique imaging process breaks the tradeoff between scan quality and speed, producing high resolution scans for faster and more efficient turnaround times.

AI-Powered Decision Support System: the digital future of smart hematology

Built on top of the breakthrough technology is Scopio’s clinical grade end-to-end AI-based Decision Support System (DSS). The powerful combination of digital microscopy with built-in AI brings detection, quantification, pre-classification and morphology visualization to the lab from large scan areas.

A True Remote Solution

Scopio facilitates seamless remote review, consultation and global collaboration with easy access to the full field view of all the scanned areas of interest, from any location.

Alternative digital microscopy solutions often result in the need to default to the manual microscope in order to complete the analysis. This is due to the lack of scan context, susceptibility of results to sample quality and the sensitivity to long or short smears. The requirement to physically access the glass slide on the manual microscope prevents a true remote solution.

Future Developments

With a robust product development pipeline, Scopio opens the door for morphology-based diagnostics, disease monitoring and treatment adjustment for various blood diseases and conditions:

A first-of-its-kind Full Field Bone Marrow Aspirate (FFM-BMA) application that enables a complete digital workflow and standardized morphological evaluation is currently under clinical studies.

Looking For

Target Market

Scopio's primary target market are hospitals who are looking to improve workflow efficiencies, standardize processes for consistency, and provide the remote digital capabilities of sharing images between a distributed lab network or for off-site, remote consultation. With Scopio's cutting-edge technology, lab technicians can now work smarter for more reliable and quality diagnoses, and reduced turnaround times.

Scopio has also launched a strategic partnership program, looking to partner with distributors in the field of healthcare and diagnostic solutions.